Private-credit & direct-lending funds

Kartesia

A pan-European private debt manager, majority-owned by New York Life Investments and Candriam, that targets lower-mid-market investments of €10m to €150m across four credit strategies.

Considering finance for your business? Discuss the lender options.

Fig. 01

Published band from £8.5m, against the other 59 private-credit and direct-lending funds.

Kartesia publishes from £8.5m.Kartesia's published facility band, from £8.5m, drawn on a logarithmic axis from £100k to £100m against the £3m to £15m band and the shaded field of the other 59 private-credit and direct-lending funds, which is taller where more of them publish a band covering that size.£3–15m£8.5m£100k£1m£10m£100m
Published facility bands: Kartesia against the other private-credit and direct-lending funds in this directory.
LenderPublished band
Kartesiafrom £8.5m
The other private-credit and direct-lending funds28 of 59 publish a band; at the field's peak 23 of them cover the same facility size
The band this directory reads for£3m to £15m

The shaded field is the other 59 private-credit and direct-lending funds in this directory, taller where more of them publish a band covering that size. Kartesia’s bar is its own published range. A band is what a lender states it will do, not what it will do on a given credit.

What they do

Kartesia describes itself as a privately owned European asset manager specialised in private corporate lending, founded in 2013 and focused on the lower mid-market. New York Life Investments and its European affiliate Candriam hold a majority stake, raised to about 80% from 33%. The firm runs four complementary strategies and states a target investment size of €10m to €150m. Kartesia Senior Opportunities, KSO, invests only in 100% first-lien secured loans, unitranche included, and its second generation raised €1.8bn against a €1.5bn target. Credit Opportunities, KCO, works across the capital structure and into special situations; its latest fund raised €1.3bn. An impact fund classified under Article 9 and a structured credit strategy complete the four. In May 2026 Kartesia also launched a European CLO platform, KLM, and it priced its first CLO that September. Since 2023 it has also been majority shareholder of Flexam, an asset-based financing manager writing finance leases and sale and leasebacks on transport and logistics assets. Kartesia works from offices across Europe, London included, and its UK entity, Kartesia UK Ltd, is FCA authorised under firm reference number 920933.

Who they lend to

Kartesia lends to European lower-mid-market companies with enterprise values of roughly €30m to €250m, and it targets EBITDA above €5m, about £4.2m. Its homepage offers credit to any European based lower mid-market borrower, and the portfolio is filed under seven regions: Benelux, central Europe, DACH, France, Italy, Spain and the UK. Industry filters run from health care, industrials and information technology to consumer, materials, financials and real estate. Kartesia does not publish a list of excluded sectors. Borrowers named in 2026 releases include a content verification software company bought by a German technology investor and a Swiss medical aesthetics group with 26 clinics. The firm finances sponsors, management teams and corporates, and it positions itself as the most active sponsorless lender in Europe, so an owner-managed business is in scope alongside private-equity buyouts. It publishes nothing on search funds.

How they structure a facility

KSO writes first-lien senior secured loans, unitranche among them, for acquisitions, buy-and-build strategies, growth and refinancing. Its 2023 unitranche for Cemedis Group, a French dental group, refinanced part of the existing debt and funded further acquisitions. KCO is flexible across the capital structure, from senior and unitranche into subordinated and junior debt and special situations, in primary and secondary positions. In 2023 Kartesia described its expertise as spanning senior debt, mezzanine, minority equity interests and CLO liabilities. Flexam adds finance leases, sale and leasebacks included, on tangible mobility, logistics and light infrastructure assets. Events funded run from acquisitions and management buyouts to growth capital, refinancing and dividend recapitalisations. Kartesia publishes no pricing, leverage cap, tenor or amortisation profile. Beyond the first-lien position of KSO loans, it does not publish its security package, and it publishes no covenant terms.

Published terms

Pricing
Not published
Published by 1 of 60
Speed to terms
Not published
Published by 8 of 60
EBITDA floor
From about £4.2m
Published by 17 of 60
Sponsored or sponsorless
Both: finances sponsors, management teams and corporates, and positions itself as the most active sponsorless lender in Europe
Where they lend
Pan-European, 7 offices; dedicated UK & Ireland coverage (London)
How they decide
Internal investment committee; local deal teams by region, with a head of UK and Ireland coverage
Security
First-lien senior secured in the KSO strategy; the security package beyond that is not published
Published by 12 of 60
Covenants
Not published
Published by 15 of 60

As published by the lender and last reviewed October 2026. Terms quoted on a deal are set by the credit, not by a published band.

How a deal reaches them

Origination runs through local deal teams in each region, and the UK and Ireland business has its own head, covering the market from London. Most 2026 releases name a sponsor alongside the borrower, and two were repeat relationships: the September 2026 unitranche was Kartesia's third deal with Maguar Capital, and the Matignon package was another deal with Rigeto. A second origination track covers sponsorless deals, so an owner-manager can approach Kartesia without a private-equity house in tow. Decisions go to an internal investment committee. Kartesia publishes no turnaround time, though the sponsor on the September 2026 deal credited its speed of execution. A borrower needs EBITDA above €5m and the preparation a private-credit fund expects, meaning an information memorandum, a built model and a complete data room. Kartesia does not publish an application process.

Where they fit in a lower-mid-market raise

Kartesia is a credible counterparty only at the very top of a £3m to £15m raise, where a sterling facility near £12m to £15m clears its €10m floor and the borrower's EBITDA clears €5m. The natural shape is a sponsored buy-and-build that needs a unitranche able to grow with the platform, as with its repeat financing of Matignon Group's acquisitions for Rigeto. A sponsorless founder or management buyout at the same scale also fits, given its second origination track. Where a deal needs structuring, Kartesia can move from senior unitranche under KSO into opportunistic capital under KCO. Beechbrook and Cordet will also write a sub-£15m cheque on its merits, while Arcmont and Barings start higher. With a stated ceiling of €150m, Kartesia can keep lending as an acquisitive borrower grows into a far larger facility.

Where they are not the fit

Below about £8.5m, roughly its €10m floor in sterling, Kartesia is the wrong counterparty: a plain £3m to £7m senior facility sits below its stated investment range, and borrowers with EBITDA under €5m fall outside its target. It does not suit the most price-sensitive raises, where a clearing bank or an asset-based lender is cheaper and quicker, nor a business that cannot carry private-credit pricing and documentation. As a fund manager it offers no transactional banking, invoice finance or day-to-day working-capital lines. A borrower that wants published pricing or a stated turnaround before engaging will find neither on its site.

What rules a deal out

Stated limits, taken from Kartesia’s own published criteria. A limit is where a lender starts from, not where it always ends: several of these move on a strong enough credit.

  • EBITDA below €5m
  • Investments below €10m or above €150m

How they sit against the category

  • Like 59 of the 60, it publishes no indicative price; a margin comes from a conversation, not a page.

Counted across the 60 private-credit & direct-lending funds in this directory, on what each one publishes. What a lender discloses and what it will do are different things.

Recent activity on the public record

In May 2026, Kartesia launched KLM, a European CLO platform, and in September 2026 it priced its first CLO. In June 2026, it partnered with NLI Capital on the acquisition of Holland ICT Groep and provided a capital solution for Foresco's acquisitive growth. In August 2026, KSO funded an additional package for Matignon Group's acquisition of The Gentlemen's Clinic, a Swiss medical aesthetics business for male patients. In September 2026, it provided unitranche finance for Maguar Capital's acquisition of a content verification software company and financing for Verdane's partnership with Konvekta; the same month it agreed a full exit from GroGlass.

Fig. 02

8 dated items in 2026, numbered as listed below.

Kartesia: 8 dated items on the public record, 2026 to 2026.1. May 2026; 2. Jun 2026; 3. Jul 2026; 4. Aug 2026; 5. Sep 2026; 6. Sep 2026; 7. Sep 2026; 8. Sep 2026202620270102030405060708
Kartesia: dated items on the public record, in order.
No.DateItem
01May 2026Kartesia launched KLM, a European CLO platform.
02Jun 2026Kartesia partnered with NLI Capital in the acquisition of Holland ICT Groep.
03Jul 2026Kartesia provided financing to support the development of OMX Group.
04Aug 2026Kartesia provided additional KSO financing for Matignon Group's acquisition of The Gentlemen's Clinic, a Swiss medical aesthetics business.
05Sep 2026Kartesia agreed a full exit from GroGlass.
06Sep 2026Kartesia priced its first CLO following the launch of its KLM strategy.
07Sep 2026Kartesia provided a unitranche from its KSO strategy for Maguar Capital's acquisition of a content verification software company, its third deal with Maguar.
08Sep 2026Kartesia provided financing to support Verdane's partnership with Konvekta.

On the record

  • May 2026: Kartesia launched KLM, a European CLO platform.

    kartesia.com

  • June 2026: Kartesia partnered with NLI Capital in the acquisition of Holland ICT Groep.

    kartesia.com

  • July 2026: Kartesia provided financing to support the development of OMX Group.

    kartesia.com

  • August 2026: Kartesia provided additional KSO financing for Matignon Group's acquisition of The Gentlemen's Clinic, a Swiss medical aesthetics business.

    kartesia.com

  • September 2026: Kartesia provided a unitranche from its KSO strategy for Maguar Capital's acquisition of a content verification software company, its third deal with Maguar.

    kartesia.com

  • September 2026: Kartesia priced its first CLO following the launch of its KLM strategy.

    kartesia.com

  • September 2026: Kartesia provided financing to support Verdane's partnership with Konvekta.

    kartesia.com

  • September 2026: Kartesia agreed a full exit from GroGlass.

    kartesia.com

  • Kartesia manages roughly €7.5bn and describes itself as a privately owned, pan-European asset manager specialising in private corporate lending to lower-mid-market borrowers, pioneering lower-mid-market direct lending in Europe.

    Kartesia, Our Expertise

  • Kartesia runs four complementary strategies; Senior Direct Lending, Opportunistic/Credit Opportunities, an Article 9 Impact fund, and Structured Credit (CLOs); and targets companies with enterprise values of roughly €30–250m.

    Kartesia, Homepage / Our Expertise

Questions this page answers

What size of investment does Kartesia make?

Kartesia says it targets investment opportunities from €10m to €150m, providing long-term liquidity and credit to European based lower mid-market borrowers. It does not publish a separate sterling range.

As published at kartesia.com

Does Kartesia lend to UK companies?

Yes. The UK is one of the regions Kartesia files its corporate portfolio under, alongside Benelux, DACH, France, Italy and Spain, and the UK holdings listed there include InvestAcc, Obsequio and Pivotal.

As published at kartesia.com

Does Kartesia lend to companies without a private-equity sponsor?

Yes. Kartesia says it provides financing to sponsors, management teams and corporates in all types of situations, so a company with no private-equity backer is not out of scope on that ground.

As published at kartesia.com

Does Kartesia provide unitranche finance?

Yes. Unitranche sits in its senior strategy, KSO: in September 2026 Kartesia provided a unitranche financing solution, deployed from KSO, for Maguar Capital's acquisition of a content verification software company.

As published at kartesia.com

Which sectors does Kartesia invest in?

Kartesia's portfolio filters cover communication services, consumer discretionary and staples, financials, health care, industrials, information technology, materials and real estate. It publishes no list of excluded sectors.

As published at kartesia.com

Does Kartesia offer asset finance or sale and leaseback?

Yes, through Flexam, in which Kartesia became majority shareholder in 2023. Flexam writes finance leases, sale and leasebacks included, on tangible assets in the European transportation and logistics industries.

As published at kartesia.com

Sources: kartesia.com · thehedgefundjournal.com

Terms used on this page: Unitranche · Sponsor · Mezzanine · Sale and leaseback · Amortisation

This profile is a curated reference note drawn from public sources, not financial advice or a recommendation. Appetite and terms change; a lender's fit for a given credit is established by approaching it, not inferred from a page.

SolonCorporate Finance

Independent debt advisory for UK lower-mid-market companies.

Discuss your financing

© 2026 Solon Corporate Finance Ltd. Registered in England & Wales, company number 17320026.

Registered office: 124 City Road, London EC1V 2NX.

Solon Corporate Finance Ltd advises on and arranges commercial debt facilities for UK companies. Arranging and advising on plain commercial lending to corporate borrowers is not a regulated activity under FSMA, and Solon is not authorised or regulated by the Financial Conduct Authority.